Viktor Zarev

Viktor Zarev

InvestorPlace Contributor

Expertise: Science, Technology, Defense, and Medicine Stock Review

Education: BS in Biology from Baylor University, MS in Computer Science from Pace University

Viktor Zarev is a Freelance Writer at InvestorPlace.com, where he aims to elucidate and simplify the world of high-tech stocks and cryptocurrencies. To accomplish this, Viktor specializes in distilling the most pertinent and critical details for investors to focus on.

He also writes in-depth research scripts for defense documentaries on YouTube as well as creative direction and copywriting for game studios. He is also a supply chain specialist in the defense industry.

Viktor holds a BS in Global Health Biology from Baylor University, where he graduated on the Medical Entomology Research Track, studying flaviviruses and developing vector control methods. He is currently earning an MS in Computer Science from Pace University, focusing on artificial intelligence and machine learning.

Recent Articles

3 Overhyped AI Stocks the Smart Money Is Fleeing Fast

By Viktor Zarev, InvestorPlace Contributor

Investors should consider taking profits on three of the most overvalued Ai stocks before a market correction.

The 3 Best Copper Mining Stocks to Buy Now: July Edition

By Viktor Zarev, InvestorPlace Contributor

These are three of the best copper mining stocks to buy for long-term value storage and a strong position in the copper industry.

3 IoT Stocks to Sell in July Before They Crash & Burn

By Viktor Zarev, InvestorPlace Contributor

These IoT stocks to sell might not have much gas left in the tank as the broader industry's potential seems somewhat obscure to investors.

3 5G Stocks to Sell in July Before They Crash & Burn

By Viktor Zarev, InvestorPlace Contributor

These are three 5G stocks to sell as their potential wanes due to financial burdens and an overall lack of competitiveness in the market.

3 Cannabis Stocks Ready to Blaze as Regulations Ease

By Viktor Zarev, InvestorPlace Contributor

These are three of the best cannabis stocks to watch as the federal government reclassifies the drug from Schedule I to Schedule III.

Load More